Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
3.605
-0.255 (-6.61%)
At close: Apr 1, 2025, 4:00 PM
3.636
+0.030 (0.85%)
After-hours: Apr 1, 2025, 4:56 PM EDT

Design Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-49.59-66.86-63.31-35.53-8.28
Upgrade
Depreciation & Amortization
0.60.540.410.130.01
Upgrade
Loss (Gain) From Sale of Investments
-6.2-6.08-1.4-0.08-0.07
Upgrade
Stock-Based Compensation
13.0713.0910.934.690.45
Upgrade
Other Operating Activities
0.010.030.060.020.04
Upgrade
Change in Accounts Payable
-1.22-1.255.392.41-0.41
Upgrade
Change in Unearned Revenue
-----0.2
Upgrade
Change in Other Net Operating Assets
0.231.97-3.39-1.02-0.2
Upgrade
Operating Cash Flow
-43.11-58.56-51.32-29.38-8.67
Upgrade
Capital Expenditures
-0.34-0.26-0.92-1.54-0.08
Upgrade
Sale of Property, Plant & Equipment
--0.04--
Upgrade
Investment in Securities
44.352.79-220.11-52.11-33.49
Upgrade
Investing Cash Flow
43.9652.54-220.99-53.64-33.56
Upgrade
Short-Term Debt Issued
----0.2
Upgrade
Total Debt Issued
----0.2
Upgrade
Short-Term Debt Repaid
-----0.4
Upgrade
Total Debt Repaid
-----0.4
Upgrade
Net Debt Issued (Repaid)
-----0.2
Upgrade
Issuance of Common Stock
0.510.720.66254.50
Upgrade
Other Financing Activities
---0.43--
Upgrade
Financing Cash Flow
0.510.720.24379.2144.53
Upgrade
Net Cash Flow
1.36-5.3-272.07296.192.3
Upgrade
Free Cash Flow
-43.45-58.82-52.24-30.92-8.75
Upgrade
Free Cash Flow Margin
-----3869.47%
Upgrade
Free Cash Flow Per Share
-0.77-1.05-0.94-0.67-0.55
Upgrade
Cash Interest Paid
----0.02
Upgrade
Levered Free Cash Flow
-26.68-34.78-29.85-17.88-5.66
Upgrade
Unlevered Free Cash Flow
-26.68-34.78-29.85-17.88-5.66
Upgrade
Change in Net Working Capital
1.02-0.72-1.98-1.240.84
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q